X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (260) 260
Publication (47) 47
Book Chapter (14) 14
Patent (11) 11
Book Review (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (128) 128
neurosciences (100) 100
humans (91) 91
rats (77) 77
male (75) 75
parkinson's disease (74) 74
index medicus (64) 64
oxidative stress (50) 50
mitochondria (40) 40
rotenone (39) 39
neurons (37) 37
parkinsons-disease (37) 37
disease models, animal (36) 36
rats, sprague-dawley (34) 34
article (32) 32
biochemistry & molecular biology (32) 32
clinical neurology (32) 32
neurodegeneration (30) 30
alpha-synuclein (29) 29
mitochondria - metabolism (29) 29
substantia-nigra (29) 29
neurons - metabolism (28) 28
neurology (27) 27
parkinson disease - metabolism (27) 27
rats, inbred lew (25) 25
brain (24) 24
brain - metabolism (23) 23
dopamine - metabolism (23) 23
female (23) 23
basal ganglia (22) 22
autoradiography (21) 21
mitochondria - drug effects (21) 21
glutamate (20) 20
parkinson’s disease (20) 20
neurons - drug effects (19) 19
mitochondrial dna (17) 17
rotenone - toxicity (17) 17
complex i (16) 16
dose-response relationship, drug (16) 16
mitochondrial complex-i (16) 16
substantia nigra - metabolism (16) 16
brain - drug effects (15) 15
dopamine (15) 15
inhibition (15) 15
parkinson disease - pathology (15) 15
analysis (14) 14
complex-i (14) 14
electron-transport chain (14) 14
mice (14) 14
neurons - pathology (14) 14
neurotoxicity (14) 14
parkinsonian disorders - chemically induced (14) 14
subthalamic nucleus (14) 14
excitotoxicity (13) 13
nadh dehydrogenase (13) 13
nerve tissue proteins - metabolism (13) 13
nervous system (13) 13
nervous system diseases (13) 13
neurodegenerative diseases (13) 13
parkinson disease - genetics (13) 13
parkinson disease - physiopathology (13) 13
parkinsons disease (13) 13
research (13) 13
dopaminergic-neurons (12) 12
mutation (12) 12
parkinson disease - etiology (12) 12
substantia nigra - drug effects (12) 12
toxicology (12) 12
corpus striatum - drug effects (11) 11
immunohistochemistry (11) 11
macaca mulatta (11) 11
middle aged (11) 11
physiological aspects (11) 11
proteins (11) 11
adult (10) 10
aged (10) 10
apoptosis (10) 10
cells, cultured (10) 10
neurons - physiology (10) 10
oxidation-reduction (10) 10
parkinson disease, secondary - chemically induced (10) 10
pathogenesis (10) 10
pesticides (10) 10
receptors, n-methyl-d-aspartate - metabolism (10) 10
risk factors (10) 10
substantia nigra - pathology (10) 10
substantia nigra - physiopathology (10) 10
cell biology (9) 9
cell death - drug effects (9) 9
degeneration (9) 9
dizocilpine maleate - pharmacology (9) 9
electron transport complex i (9) 9
gene expression (9) 9
huntington disease - genetics (9) 9
lewy bodies (9) 9
mitochondria - enzymology (9) 9
nerve tissue proteins - genetics (9) 9
neuroprotection (9) 9
parkinson disease - drug therapy (9) 9
parkinsonian disorders - genetics (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Brain Research, ISSN 0006-8993, 12/2015, Volume 1628, Issue Pt B, pp. 247 - 253
Parkinson's disease (PD) is the second most common neurodegenerative disease, and the most prevalent degenerative movement disorder. It is estimated that the... 
Post-translational modification | Oxidative stress | Parkinson's disease | Alpha-synuclein | Lewy neurite | Lewy body | Brain - metabolism | Parkinson Disease - pathology | Animals | Humans | Parkinson Disease - metabolism | alpha-Synuclein - metabolism | Protein Processing, Post-Translational - physiology
Journal Article
Science, ISSN 0036-8075, 5/2004, Volume 304, Issue 5674, pp. 1120 - 1122
Journal Article
Neurology, ISSN 0028-3878, 02/2019, Volume 92, Issue 7, pp. 329 - 337
The gold standard for a definitive diagnosis of Parkinson disease (PD) is the pathologic finding of aggregated α-synuclein into Lewy bodies and for Alzheimer... 
BIOMARKERS | TRIALS | DEMENTIA | SOLANEZUMAB | OLDEST-OLD | DUPLICATION | ALPHA-SYNUCLEIN | PATHOLOGY | ONSET | CLINICAL NEUROLOGY | BETA
Journal Article
Movement Disorders, ISSN 0885-3185, 12/2016, Volume 31, Issue 12, pp. 1800 - 1801
Journal Article
Journal Article
Laboratory Investigation, ISSN 0023-6837, 2018, Volume 99, Issue 7, pp. 1068 - 1077
Huntington’s disease (HD) is an autosomal dominant disorder caused by a trinucleotide expansion in the huntingtin gene. Recently, a new role for tau has been... 
Immunohistochemistry | Huntingtons disease | Phosphorylation | Neurodegenerative diseases | Huntingtin | Astrocytes | Pathogenesis | Males | Huntington's disease | Trauma | Low level | Neuronal-glial interactions | Hereditary diseases | Pathology | Chronic traumatic encephalopathy | Tau protein | Autopsy | Encephalopathy | Neostriatum | Contact sports | Aging | Diagnostic systems | Females | Age
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 02/2017, Volume 65, Issue 2, pp. 446 - 446
Journal Article
LABORATORY INVESTIGATION, ISSN 0023-6837, 07/2019, Volume 99, Issue 7, pp. 1068 - 1077
Huntington's disease (HD) is an autosomal dominant disorder caused by a trinucleotide expansion in the huntingtin gene. Recently, a new role for tau has been... 
MEDICINE, RESEARCH & EXPERIMENTAL | ALZHEIMERS ASSOCIATION GUIDELINES | NATIONAL INSTITUTE | PROTEIN | FUS | FUS/TLS | AMYOTROPHIC-LATERAL-SCLEROSIS | INTRANUCLEAR INCLUSIONS | PATHOLOGY | FRONTOTEMPORAL LOBAR DEGENERATION | CHRONIC TRAUMATIC ENCEPHALOPATHY | NEUROPATHOLOGIC ASSESSMENT
Journal Article
TOXICOLOGICAL SCIENCES, ISSN 1096-6080, 07/2019, Volume 170, Issue 1, pp. 133 - 143
There is a critical need to include female subjects in disease research; however, in Parkinson's disease, where the male-to-female incidence is about 1.5-to-1,... 
Parkinson's disease | rotenone | neurodegeneration | MECHANISMS | MODEL | DEGUELIN | BRAIN FERRITIN IRON | toxin models | NEUROINFLAMMATION | IN-VIVO | ESTROGEN | GENDER | TOXICOLOGY | sex differences | AGE
Journal Article
Neurology, ISSN 0028-3878, 09/2015, Volume 85, Issue 10, pp. 838 - 839
Journal Article
Brain Research, ISSN 0006-8993, 12/2015, Volume 1628, p. 247
Parkinson's disease (PD) is the second most common neurodegenerative disease, and the most prevalent degenerative movement disorder. It is estimated that the... 
Post-translational modification | Medicine, Experimental | Nitration | Medical research
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 10/2018, Volume 38, Issue 44, pp. 9375 - 9382
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 05/2019, Volume 125, pp. 146 - 153
α-Synuclein plays a central role in the pathogenesis of Parkinson's disease (PD); interventions that decrease its expression appear neuroprotective in PD... 
RISK-FACTORS | SHRNA | PARKINSONISM | IN-VIVO | NEURONS | MICE | TOXICITY | MODEL | SIRNA DELIVERY | NEUROSCIENCES | GENOME-WIDE ASSOCIATION
Journal Article
Redox Biology, ISSN 2213-2317, 06/2019, Volume 24, p. 101164
Impaired mitochondrial function has been associated with the etiopathogenesis of Parkinson's disease (PD). Sustained inhibition of complex I produces... 
Oxidative stress | Mitochondria | Inflammation | Parkinson's disease | Phenothiazine | Rotenone | METHYLENE-BLUE | VESICLES | BIOCHEMISTRY & MOLECULAR BIOLOGY | NEURODEGENERATION | ALPHA-SYNUCLEIN | SUBSTANTIA-NIGRA | DEGENERATION | TRANSPORT | COMPLEX-I | NEURONAL DEATH | MORPHOLOGY
Journal Article
The Journal of Neuroscience, ISSN 0270-6474, 10/2018, Volume 38, Issue 44, p. 9375
The greatest unmet therapeutic need in Parkinson's disease (PD) is a treatment that slows the relentless progression of the symptoms and the neurodegenerative... 
Parkinson's disease | Neurodegenerative diseases | Medical treatment | Parkinsons disease | Partnerships | Synuclein | Drug development | Kinases | Optimization | Substrates | Design optimization | Genetics | Glucosylceramidase | LRRK2 protein | Movement disorders
Journal Article
Journal Article